FDA Inspection 992591 — Hyland's Consumer Health Inc.

Hyland's Consumer Health Inc. — FEI 2010939

The FDA completed an inspection of Hyland's Consumer Health Inc. on October 27, 2016 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 27, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
202821 CFR 211.192Extent of discrepancy, failure investigations
241921 CFR 211.198(a)Complaint Handling Procedure
359221 CFR 211.110(c)In-process materials characteristics testing
432521 CFR 211.110(a)Control procedures fail to include the following